# Arcadia Biosciences, Inc. (RKDA) — delisting/forced [announced]
Source: SEC API (secapi.ai) · situation sit_a46f69a888d6c3100c9a · retrieved 2026-08-12T07:21:38.459Z

## Overview
Arcadia has leveraged its history as a leader in science-based approaches to develop high value products and drive innovation in the consumer goods industry.

On August 4, 2026, Arcadia Biosciences, Inc. received notice from Nasdaq that it failed to maintain the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market under Listing Rule 5550(a)(2). The company's closing bid price fell below $1.00 for 30 consecutive business days from June 22, 2026 to August 3, 2026. Nasdaq has granted an initial 180-calendar-day compliance period ending February 1, 2027, during which the company's common stock will continue trading under symbol "RKDA." To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days. If the company fails to comply by February 1, 2027, it may be eligible for an additional 180-day compliance period, provided it meets other continued listing requirements and provides written notice to Nasdaq of its intention to cure the deficiency, potentially through a reverse stock split.

## Terms
- Counterparty: The Nasdaq Stock Market LLC · Price/share: $1

## Key dates
- Announced 2026-08-07 · Expiry 2027-02-01

## Timeline
- 2026-08-07 · 8-K (0001193125-26-340664): 8-K - Arcadia Biosciences, Inc. — *Arcadia has leveraged its history as a leader in science-based approaches to develop high value products and drive innovation in the consumer goods industry.* On August 4, 2026, Arcadia Biosciences, Inc. received notice from Nasdaq that it failed to maintain the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market under Listing Rule 5550(a)(2). The company's closing bid price fell below $1.00 for 30 consecutive business days from June 22, 2026 to August 3, 2026. Nasdaq has granted an initial 180-calendar-day compliance period ending February 1, 2027, during which the company's common stock will continue trading under symbol "RKDA." To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days. If the company fails to comply by February 1, 2027, it may be eligible for an additional 180-day compliance period, provided it meets other continued listing requirements and provides written notice to Nasdaq of its intention to cure the deficiency, potentially through a reverse stock split.
  https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-340664.txt

## Citations
- 0001193125-26-340664 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526340664